Guidelines for Antiretroviral Therapy & Management of Opportunistic Infections for Children, Adolescents & Adults Living with HIV
11 December 2023
| Country mission
Overview
This guideline aims to provide guidance and support to health care workers involved in
the HIV/AIDS clinical management, including ART and OI, in Timor-Leste. Recently,
WHO has come out with many new updates based on the evidence from other clinical
trials. The latest guideline brought out in July 2019 provides an evidence-based
recommendation for use of dolutegravir-based triple ART.
The national guideline development has been developed in close consultation with the
Technical Working Group for ART in Timor-Leste and supported by WHO. The guideline
aims at:
1. Revising and consolidating existing ART and OI guidelines and incorporate
WHO recommendations for all age groups, gender and populations
2. Providing a standard approach for the use of ART with uniform recording and
reporting formats
3. Providing a transition plan for shifting to dolutegravir-based regimen.
WHO is committed to continue its support to the national program to End Inequities
and End AIDS and to ensure that the country can meet the target of elimination of AIDS
as a public health problem by 2030
WHO Team
Timor-Leste